| |
|
II. STUDY DESIGN AND METHODOLOGY
This study employs a qualitative, case study approach to
identifying transplant center practices that are associated
with high organ transplantation rates, while maintaining expected
or higher than expected patient and graft survival outcomes.
In order to identify and spread these best practices to transplant
programs across the country to help them effectively grow,
a sample of 15 transplant centers and 34 organ programs that
are among the National leaders in number of organs transplanted
with expected or higher than expected outcomes was selected
for this study. The primary sources of data on the factors
that contribute to success in high organ transplantation rates
were face-to-face interviews with staff of transplant centers.
In total, more than 450 people were interviewed for this study.
Following the data collection phase of the study, the findings
were analyzed, and best practices were assembled.
A. Site Selection
Transplant centers were selected for this study using data
from the Organ Procurement and Transplantation Network (OPTN)
provided by HRSA. Data for 275 institutions were provided,
which included deceased donor transplant volume from 2000
to the first 6 months of 2006 for heart, kidney, liver, lung,
and pancreas transplants. Six Veterans Affairs transplant
centers were excluded from the analysis, resulting in a final
sample size of 269 centers. The transplant volume data were
combined with quality measures for each center and type of
organ transplanted to rank each center and program.
To rank and select the high-performing transplant centers
and organ programs, the following four criteria were used
to measure volume, growth, and quality:
- High Volume: Centers in the top 10 percent
for number of transplants performed in 2005 and in the top
10 percent for average number of transplants performed from
2000 to 2006.
- High Growth: Centers in the top 10 percent
for average annual absolute change from 2000 to 2005. Absolute
change is the number of transplants from one year to the
next.
- Low Graft Failures: Centers with lower
than expected graft failures 3 years post-transplant. The
methodology utilized by the Scientific Registry of Transplant
Recipients (SRTR) was followed.
- Low Patient Mortality: Centers with
lower than expected patient mortality 3 years post-transplant.
The methodology utilized by the SRTR was followed.
The following additional criteria were also considered when
selecting the high-performing centers and programs:
- Donor information (percent SCD/ECD/DCD)
- Whether the center performs pediatric transplants
- Geographic diversity
- Percent imported organs
- Waitlist mortality
- Organ type representation
The data used for the site selection process had several
limitations. First, pancreas quality data, including observed
versus expected graft failures and patient mortality, were
not available. Therefore, the pancreas transplant programs
were only analyzed in terms of volume and growth in number
of transplants performed from 2000-2006. Another limitation
was missing data on number of transplants. If a center’s data
on number of transplants were missing for any year between
2000 and 2006, the center was excluded from the analysis.
These centers were excluded because no trend data were available
for the center to determine if it was a high volume or high
growth center. Lastly, given that recent data may best reflect
current practices, we included the incomplete 2006 data and
doubled the number of transplants in an attempt to estimate
volume for the entire year.
Exhibit 1 lists the high-performing transplant
centers and organ programs that were selected for the study
based on the data analysis. Appendix C includes data on organ
transplantation rates and patient and graft survival outcomes
for these centers and programs.
Exhibit 1:
Selected High-Performing Transplant Centers and Organ Programs
| City,
State |
Institution |
Organ
Program(s) |
| Rochester,
MN |
Mayo
Clinic |
Liver |
| Jacksonville,
FL |
St.
Luke's Hosital (Mayo Clinic) |
Liver |
| Scottsville,
AZ |
Mayo
Clinic |
Liver,
Kidney |
| Cleveland,
OH |
Cleveland
Clinic |
Liver,
Lung, Heart, Pancreas |
| Philadelphia,
PA |
The
Hospital of the University of Pennsylvania |
Liver,
Heart, Kidney, Lung |
| Philadelphia,
PA |
Hahnemann
University Hospital |
Kidney |
| Philadelphia,
PA |
Children's
Hospital of Philadelphia |
Heart,
Kidney, Liver |
| San
Francisco, CA |
University
of California, San Francisco Medical Center |
Heart,
Kidney, Liver |
| San
Francisco, CA |
Stanford
University |
Heart,
Kidney |
| San
Francisco, CA |
California
Pacific Medical Center |
Kidney |
| Indianapolis,
IN |
Clarian
Health - Methodist/Indiana University/Riley |
Kidney,
Lung, Liver, Pancreas |
| Seattle,
WA |
University
of Washington Medical Center |
Liver,
Lung |
| New
York, NY |
New
York-Presbyterian Hospital/Columbia University Medical
Center |
Heart,
Lung, Kidney |
| New
York, NY |
New
York-Presbyterian Hospital/Columbia University Medical
Center |
Kidney |
| Durham,
NC |
Duke
University Medical Center |
Heart,
Lung |
B. Data Collection and Synthesis
HRSA extended invitations by email to transplant center
leadership to participate in the study. All of the selected
transplant centers accepted. Background information about
the transplant centers was collected through the centers’
Web sites.
Site visits were used to collect data on best practices of
transplant centers that have achieved high rates of organ
transplantation, while maintaining expected or higher than
expected patient and graft survival outcomes. These site visits
involved extensive series of in-person discussions with transplant
center staff. Transplant centers recommended key informants
for these discussions. Depending on the preferences and availability
of key informants at each transplant center, discussions were
conducted either individually or in a group. Individual discussions
ranged from 30 to 60 minutes in length; group discussions
lasted as long as 2 hours.
Discussions with informants did not follow a strict format.
The purpose of these discussions was to determine what the
informants perceived, from their various perspectives, to
be the factors that contribute to the high rates of organ
acceptance and transplantation, while maintaining expected
or higher than expected patient and graft survival outcomes.
Informants usually identified what they considered to be the
most important factors or practices associated with accepting
and transplanting more organs. More extensive probing of informants’
initial observations and inquiring about general areas of
potential that they did not cite initially (which varied across
informants), provided the opportunity to identify other relevant
factors.
Probes addressed transplant center policies, procedures,
management, administrative, and other clinical, behavioral,
cultural, organizational, and financial practices associated
with high performance in organ acceptance, transplantation,
and outcomes. The following are examples of areas probed:
- Overall success factors
- Transplant center leadership and commitment
- Business/financial arrangements and issues
- Operations and communications
- Social, behavioral, and cultural factors
- Staffing issues
- Clinical practices in organ recovery, transplant, and
post-transplant management
- Planning and evaluation activities
- Information technology and data collection capacity
- Interaction with OPO
Standards for answers included concrete, descriptive language,
consistency, and evidence,
where relevant. Wherever possible, opinions were grounded
with specific examples; when they
were not, they were recorded as ungrounded for study purposes.
In total, 465 individuals were interviewed for this study,
including transplant surgeons, physicians, nurse coordinators/managers,
social workers, transplant administrative staff, leadership/administration,
other physicians, and non-physician clinicians. Exhibit
2 shows the distribution of interviewees by staff
type and by site visited.
Qualitative data from on-site interviews were analyzed in
both an internal and external debriefing process. Internal
debriefings were conducted throughout the site visit process
during which team members reviewed site visit experiences
and observations on-site and shared themes with other off-site
team members in real-time, so they could be tested during
concurrent and/or subsequent site visits. External debriefings
were also conducted on the last day of each site visit with
key transplant center staff interviewed, HRSA Division of
Transplantation (DoT) staff, and HRSA guests from other transplant
centers and organizations. The purpose of these debrief meetings
was to review and validate the site visit findings and emerging
best practices.
After the site visits were completed, data were compiled
and analyzed to assemble a Change Package Document,
consisting of a set of strategies/drivers and corresponding
key change concepts and action items associated with high
organ transplantation rates and expected or higher than expected
patient and graft survival outcomes. The Change Package
Document, including the strategies/drivers, key change
concepts, and action items, was vetted with an expert panel
that included representatives from transplant centers included
in the study and HRSA guests from other transplant centers
and organizations. Appendix
A and Appendix
B include a copy of the Change Package Document
and a list of the expert panel members, respectively.
C. Study Limitations
The purpose of this study was not to isolate true cause-and-effect
relationships between practices and performance measures,
but to identify promising or likely best practices and to
seek to validate them across sites. This was essentially a
retrospective observational study intended to identify practices
conducted to date that are likely to have contributed to recent
historical (2000-2006) performance in terms of organs transplanted
and patient and graft survival outcomes. This study is an
initial phase of identifying and sharing “what works” across
transplant centers to obtain higher numbers of organs accepted
and transplanted.
For the purpose of identifying true best practices (i.e.,
that are known to be causally related to high performance
in transplantation and outcomes), this study has several limitations,
including the following.
- Small sample. Due to time and resource
constraints, only a limited number of site visits could
be conducted for this study. Based upon just this sample
of 15 transplant centers, it is evident that organ acceptance
and transplantation and patient care practices vary across
the country. As a result, other best practices might not
have been identified within the limited scope of this study.
Also, certain practices considered to be “best” based on
their appearance in some or all of this limited sample might
not have been confirmed as such given a larger sample of
observations. Similarly, some best practices among our sample
of transplant centers may be artifacts or otherwise specific
to those institutions, and therefore, not generalizable
to other institutions.
- No control group. This study did not
compare the practices of higher-performing transplant centers
with the practices of lower-performing centers. Including
such controls in this study would have enabled a more valid
distinction between practices that simply co-exist with,
but do not contribute to, higher performance and those practices
that exist more often in higher-performing centers and less
often in lower-performing centers.
- Limited perspectives. The practices
that contribute to higher performance in organ transplantation
and outcomes involve or affect many parties. Although information
was collected about potential best practices from a wide
range of transplant center staff who, as a group, are very
likely to be aware of most potential existing best practices,
it is possible that some best practices were overlooked
by not involving other parties with perspectives not encompassed
in this study. In particular, given the limited study scope,
the study team did not have the opportunity to hear the
perspectives of transplant recipients and families involved
in the organ transplant process.
- Halo effect.30
In this best practices study, transplant center staff were
aware that they were participating in a study based on their
higher numbers of organs transplanted and expected or higher
than expected patient and graft survival outcomes and were
being asked to identify (i.e., observe and report) what
factors might contribute to this. The transplant centers
may have considered that, ‘We must be doing something
right,’ or, ‘Whatever we’re doing must be working,’
and categorized some practices not associated with more
organs transplanted and expected or higher than expected
patient and graft survival outcomes as “best” practices.
To diminish the impact of the halo effect, to the extent
possible, best practices were validated or c onfirmed
across multiple sites.
- Hawthorne effect.31 Rather than being an
interventional study, this was a retrospective observational
study of best practices. Interviewees were aware of being
observed; however, the observations were of potential causes
of effects (e.g., number of organs transplanted that had
been recorded previously). Although this was not a setting
for the Hawthorne effect in its traditional form, there
may be a Hawthorne effect at work affecting future performance.
Many interviewees have noted that, as a result of being
visited and interviewed and having the opportunity to reflect
on their work, they identified what they had previously
considered to be certain typical routine practices as being
likely best practices. Aside from contributing to a potential
halo effect as described above, this may enable sites to
codify and track these practices internally and share them
with others when they might not otherwise have done so.
Further, some interviewees noted that the reflection prompted
by the interview process, as well as the feedback provided
to them about their center’s high performance, have led
to performance improvements. While unintentional, this effect
reportedly has motivated staff at the sites to rethink how
they might improve existing policies, procedures, and practices
and may have left the “observed” sites in a stronger position
to think creatively and mobilize toward further improvements
that might benefit themselves as well as others through
the sharing of the study’s best practices.32
30The halo effect refers to a bias in observation or measurement
that reflects an observer’s tendency to rate, perhaps unintentionally,
a person or event or other phenomenon in a manner that is
consistent with what the observer anticipated.
31In the Hawthorne effect, the act itself of observing people
may prompt them to change their behavior. This might result,
for instance, in subjects improving their performance due
to their knowledge of being observed rather than due to an
intervention such as training or use of some technology.
32Similarly,
in describing how the Hawthorne effect can contribute to improved
performance, S.W. Draper notes, “This might be because attention
made the workers feel better; or because it caused them to
reflect on their work and [this] reflection caused performance
improvements, or because the experimental situation provided
them with performance feedback they didn’t otherwise have
and this extra information allowed improvements.” (Draper
SW, University of Glasgow, 2005 ). |